Phase II Study of Low-dose Everolimus Plus Weekly Cisplatin and 24-hour Infusion of High-dose 5-fluorouracil and Leucovorin for First-line Treatment of Metastatic or Recurrent Gastric Cancers

被引：1
|
作者：
Yeh, K. [1 ]
Shen, Y. C. [1 ]
Li, C. P.
Yen, C. J. [3 ]
Lin, Y. L. [1 ]
Lin, Z. Z. [1 ]
Chen, L. T. [4 ]
Su, W. C. [3 ]
Chao, Y. [2 ]
Cheng, A. L. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan
[3] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan
[4] Natl Hlth Res Inst, Tainan, Taiwan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71896-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [31] A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer
    Maurie Markman
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 353 - 353
  • [32] A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer
    Markman, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (07) : 353 - 353
  • [33] RANDOMIZED PHASE II STUDY OF CISPLATIN AND HIGH-DOSE 5-FLUOROURACIL/LEUCOVORIN OR PACLITAXEL AND HIGH-DOSE 5-FLUOROURACIL/LEUCOVORIN IN LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER AND ADENOCARCINOMAS OF THE GASTRO-OESOPHAGEAL JUNCTION
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Pruijt, H.
    Ouwerkerk, J.
    Sleeboom, H.
    Tesselaar, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 173 - 174
  • [34] Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma
    Lin, Chia-Chi
    Hsu, Chih-Hung
    Huang, Chao-Yuan
    Cheng, Ann-Lii
    Vogelzang, Nicholas J.
    Pu, Yeong-Shiau
    JOURNAL OF UROLOGY, 2007, 177 (01): : 84 - 89
  • [35] A phase II study of irinotecan alternated with a weekly schedule of high-dose leucovorin and 48-hour 5-fluorouracil infusion in patients with metastatic colorectal cancer
    Rosati, G
    Rossi, A
    Reggiardo, G
    Manzione, L
    ONCOLOGY, 2002, 62 (03) : 209 - 215
  • [36] Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
    Wein, A
    Riedel, C
    Köckerling, F
    Martus, P
    Baum, U
    Brueckl, WM
    Reck, T
    Ott, R
    Hänsler, J
    Bernatik, T
    Becker, D
    Schneider, T
    Hohenberger, W
    Hahn, EG
    ANNALS OF ONCOLOGY, 2001, 12 (12) : 1721 - 1727
  • [37] Randomized, phase II study comparing cisplatin and high-dose 5-fluorouracil/leucovorin with paclitaxel and high-dose 5-fluorouracil/leucovorin in patients with advanced gastric cancer and adenocarcinomas of the gastroesophageal junction
    Tesselaar, M. E.
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Ouwerkerk, J.
    Pruijt, H.
    Sleeboom, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer
    Chiara, S
    Nobile, MT
    Gozza, A
    Taveggia, P
    Heouaine, A
    Pastrone, I
    Percivale, PL
    Lionetto, R
    Sanguineti, O
    Rosso, R
    ANTICANCER RESEARCH, 2004, 24 (01) : 355 - 360
  • [39] Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
    Klaassen, U
    Wilke, H
    Harstrick, A
    Pari, CP
    Strumberg, D
    Newmann, K
    Eberhardt, W
    Achterrath, W
    Lenaz, L
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 (01) : 45 - 50
  • [40] Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV)
    Roehrig, Sandra
    Wein, Axel
    Albrecht, Heinz
    Konturek, Peter C.
    Reulbach, Udo
    Maennlein, Gudrun
    Wolff, Kerstin
    Ostermeier, Nicola
    Hohenberger, Werner
    Hahn, Eckhart
    Boxberger, Frank
    MEDICAL SCIENCE MONITOR, 2010, 16 (03): : CR124 - CR131
12345